Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
<p>Abstract</p> <p>Background</p> <p>An increasing number of studies support the presence of stem-like cells in human malignancies. These cells are primarily responsible for tumor initiation and thus considered as a potential target to eradicate tumors. CD133 has been i...
Main Authors: | Wang Lei, Sasai Ken, Kimura Taichi, Tabu Kouichi, Bizen Norihisa, Nishihara Hiroshi, Taga Tetsuya, Tanaka Shinya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/39 |
Similar Items
-
Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments
by: Tetsuya Taga, et al.
Published: (2020-09-01) -
Impact of ERK5 on the Hallmarks of Cancer
by: Barbara Stecca, et al.
Published: (2019-03-01) -
<it>O</it><sup><it>6</it></sup>-<it>methylguanine-DNA methyltransferase </it>is downregulated in transformed astrocyte cells: implications for anti-glioma therapies
by: Kaneko Sadao, et al.
Published: (2007-06-01) -
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
by: Borger Darrell R, et al.
Published: (2010-12-01) -
Generation of Anti-CD133 Human Synthetic Antibodies as Tools for Exploring CD133 Function
by: Williams, Rashida
Published: (2013)